Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Carbamoylcholine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 known ✓ | P20309 | 6/20 | 0.95 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.95 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.95 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.95 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.95 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.91 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.91 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.91 |
| ▸ | HTR1A | P08908 | 2/20 | 0.91 |
| ▸ | LMNA | P02545 | 2/20 | 0.91 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.91 |
| ▸ | TSHR | P16473 | 1/20 | 0.91 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.58 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.58 |
| ▸ | PGR | P06401 | 1/20 | 0.58 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.58 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbamoylcholine SCHEMBL27544830 | 0.98 | CHRM5 (0.91) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Carbamoylcholine SCHEMBL21067459 | 0.98 | CHRM1 (0.95) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Carbamoylcholine SCHEMBL4727962 | 0.98 | CHRM1 (0.95) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Carbamoylcholine SCHEMBL2791 | 0.98 | CHRM5 (1.00) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Carbamoylcholine SCHEMBL5060882 | 0.98 | CHRM5 (1.00) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Carbamoylcholine SCHEMBL9792915 | 0.95 | CHRM1 (0.91) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Carbamoylcholine SCHEMBL21433743 | 0.95 | CHRM1 (0.91) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Carbamoylcholine SCHEMBL15094513 | 0.95 | CHRM5 (0.95) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Carbamoylcholine SCHEMBL21197429 | 0.95 | CHRM5 (0.95) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| Carbamoylcholine SCHEMBL9109254 | 0.95 | CHRM5 (0.95) | CHRM5CHRM1CHRM3CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5908866-A | VISION DEFECTS | ASTRA AKTIEBOLAG (SE) | 1999-06-01 | — | — | US | claimed |
| EP-0661968-B1 | PHARMACEUTICAL COMPOSITION CONTAINING CARBACHOL AND OTHER CHOLINERGIC SUBSTANCES | ASTRA AB (SE) | 1998-10-14 | — | — | EP | claimed |
| US-5679713-A | TOPICAL TREATMENT OF DRY EYE DISEASE (KERATOCONJUNCTIVITIS SICCA) IN HUMAN AND OTHER MAMMALS | ASTRA AKTIEBOLAG (SE) | 1997-10-21 | — | — | US | claimed |
| EP-0661968-A1 | PHARMACEUTICAL COMPOSITION CONTAINING CARBACHOL AND OTHER CHOLINERGIC SUBSTANCES | Astra Aktiebolag (SE) | 1995-07-12 | — | — | EP | claimed |
| WO-1993003718-A1 | PHARMACEUTICAL COMPOSITION CONTAINING CARBACHOL AND OTHER CHOLINERGIC SUBSTANCES | AKTIEBOLAGET ASTRA (SE) | 1993-03-04 | — | — | WO | claimed |
| EP-0528776-A1 | Pharmaceutical composition containing carbachol and other cholinergic substances | AKTIEBOLAGET ASTRA (SE) | 1993-02-24 | — | — | EP | claimed |
| EP-4727533-A2 | SYNTHESIS OF 2-(CARBAMOYLOXY)-N,N,N-TRIMETHYLETHAN-1-AMINIUM SALTS | Visus Therapeutics, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20250221923-A1 | BOOSTING OSMOTIC BLOOD-ORGAN BARRIER OPENING FOR IMPROVED DELIVERY OF THERAPEUTICS TO ORGANS | UNIVERSITY OF MARYLAND, BALTIMORE | 2025-07-10 | — | — | US | disclosed |
| WO-2024259258-A2 | SYNTHESIS OF 2-(CARBAMOYLOXY)-N,N,N-TRIMETHYLETHAN-1-AMINIUM SALTS | VISUS THERAPEUTICS, INC. (US) | 2024-12-19 | — | — | WO | disclosed |
| CN-119053608-A | Novel compound, conjugated polymer, method for producing same, composition for film formation, organic thin film, and organic semiconductor element | 东曹株式会社 | 2024-11-29 | — | — | CN | disclosed |
| US-20240009269-A1 | MEMBRANE-ACTIVE PEPTIDES AND METHODS FOR REVERSIBLE BLOOD- BRAIN BARRIER OPENING | THE JOHNS HOPKINS UNIVERSITY (US) | 2024-01-11 | — | — | US | disclosed |
| EP-3597262-B1 | FORMULATION FOR INTRACUTANEOUS INJECTION | XERIS PHARMACEUTICALS INC (US) | 2023-12-27 | — | — | EP | disclosed |
| US-20220296736-A1 | ADMINISTRATION OF THERAPEUTIC AGENTS TO BRAIN AND OTHER CELLS AND TISSUE | THE JOHNS HOPKINS UNIVERSITY (US) | 2022-09-22 | — | — | US | disclosed |
| US-5010056-A | Growth disorders | PIERREL SPA (IT) | 1991-04-23 | — | — | US | disclosed |
| EP-0301392-A1 | Pharmaceutical composition for intranasal administration comprising GH - Releasing hormone, a cholinergic agonist and in case a bile salt | Pierrel S.p.A. (IT) | 1989-02-01 | — | — | EP | disclosed |
| US-4459309-A | Compositions and methods of lowering intraocular pressure in the hypertensive mammalian eye | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 1984-07-10 | — | — | US | disclosed |
| EP-0051604-A1 | COMPOSITIONS AND METHODS OF LOWERING INTRAOCULAR PRESSURE IN THE HYPERTENSIVE MAMMALIAN EYE | CHIOU, George C.Y. (US) | 1982-05-19 | — | — | EP | disclosed |
| WO-1981003123-A1 | COMPOSITIONS AND METHODS OF LOWERING INTRAOCULAR PRESSURE IN THE HYPERTENSIVE MAMMALIAN EYE | CHIOU G | 1981-11-12 | — | — | WO | disclosed |
| EP-0004835-B1 | ETHANOLAMINE COMPOUNDS, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR MEDICINAL USE | Aktiebolaget DRACO (SE) | 1981-10-14 | — | — | EP | disclosed |
| US-4171353-A | Immunization of animals using choline esters as an immunological adjuvant | RYAN WAYNE L | 1979-10-16 | — | — | US | disclosed |